Ibex Wealth Advisors decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 30.4% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 27,442 shares of the healthcare conglomerate’s stock after selling 12,006 shares during the period. Ibex Wealth Advisors’ holdings in UnitedHealth Group were worth $10,073,000 at the end of the most recent reporting period.
Several other institutional investors have also added to or reduced their stakes in UNH. Nvwm LLC boosted its holdings in shares of UnitedHealth Group by 89.2% in the 3rd quarter. Nvwm LLC now owns 70 shares of the healthcare conglomerate’s stock valued at $26,000 after purchasing an additional 33 shares in the last quarter. Wellington Altus USA Inc. increased its stake in shares of UnitedHealth Group by 97.1% in the 2nd quarter. Wellington Altus USA Inc. now owns 67 shares of the healthcare conglomerate’s stock valued at $28,000 after purchasing an additional 33 shares during the last quarter. Security National Bank of SO Dak acquired a new position in shares of UnitedHealth Group during the 2nd quarter worth $29,000. Compass Wealth Management LLC bought a new stake in shares of UnitedHealth Group during the 3rd quarter worth $29,000. Finally, Aberdeen Wealth Management LLC bought a new stake in shares of UnitedHealth Group during the 2nd quarter worth $31,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of research firms have issued reports on UNH. KeyCorp reiterated an “overweight” rating on shares of UnitedHealth Group in a research report on Wednesday, October 14th. TD Cowen reissued a “hold” rating and issued a $402.00 target price on shares of UnitedHealth Group in a report on Thursday, October 15th. Mizuho raised their price target on shares of UnitedHealth Group from $493.00 to $500.00 and gave the company an “outperform” rating in a research note on Thursday, October 22nd. Raymond James Financial reaffirmed an “outperform” rating and set a $450.00 price target on shares of UnitedHealth Group in a report on Thursday, October 15th. Finally, Argus increased their price objective on shares of UnitedHealth Group from $400.00 to $470.00 and gave the company a “buy” rating in a research note on Monday, July 20th. Twenty research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus price target of $463.93.
Check Out Our Latest Analysis on UnitedHealth Group
Insider Activity
In other news, CEO Patrick Conway sold 1,169 shares of UnitedHealth Group stock in a transaction on Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the transaction, the chief executive officer owned 15,328 shares in the company, valued at approximately $5,977,920. The trade was a 7.09% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.19% of the company’s stock.
Recent UnitedHealth Group Headlines
Investors following UNH have been watching these headlines:
- Positive Sentiment: Optum Rx reported higher operating earnings in the third quarter of 2026 despite lower prescription volumes. Biosimilar adoption and operating efficiencies helped offset pressure, demonstrating the segment’s ability to grow profitability amid membership challenges. Article: Can UNH’s Optum Rx Sustain Profit Growth as Prescription Volumes Fall?
- Positive Sentiment: Recent commentary says analysts remain optimistic, and another article argues the shares may still be below fair value. It cites board changes and a sharper focus on medical-cost management and pricing as factors that could support earnings, though valuation depends on execution. Article: Do Wall Street Analysts Like UnitedHealth Group Stock? Article: UnitedHealth Group Stock Still Looks Below Fair Value After Board Appointment
- Neutral Sentiment: A technical analysis described UNH as consolidating, with neutral momentum and thin volume, suggesting no strong near-term signal from trading activity. Article: UnitedHealth Stock Price Prediction
UnitedHealth Group Trading Up 0.6%
UnitedHealth Group stock traded up $2.49 during trading hours on Friday, hitting $407.62. The stock had a trading volume of 3,467,004 shares, compared to its average volume of 5,162,694. The business’s 50 day simple moving average is $391.36 and its 200-day simple moving average is $365.66. UnitedHealth Group Incorporated has a one year low of $255.96 and a one year high of $461.62. The stock has a market cap of $365.23 billion, a price-to-earnings ratio of 23.28, a P/E/G ratio of 1.47 and a beta of 0.51. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.66.
UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.14 by $0.55. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The business had revenue of $112.72 billion during the quarter, compared to analyst estimates of $111.31 billion. During the same quarter last year, the business earned $2.59 EPS. The firm’s quarterly revenue was down .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. On average, equities analysts predict that UnitedHealth Group Incorporated will post 20.61 EPS for the current fiscal year.
UnitedHealth Group Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Monday, December 7th will be given a $2.32 dividend. This represents a $9.28 annualized dividend and a yield of 2.3%. The ex-dividend date is Monday, December 7th. UnitedHealth Group’s dividend payout ratio is 53.00%.
UnitedHealth Group Company Profile
UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.
See Also
- Five stocks we like better than UnitedHealth Group
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
